<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Dechra announces lower starting dose for Vetoryl</title><link>/b/veterinary-news/posts/117845</link><description> Dechra Veterinary Products has announced a new lower recommended starting dose of Vetoryl (trilostane), its treatment for dogs with Cushing&amp;#39;s syndrome. 
 Dechra says the change to the Summary of Product Characteristics for Vetoryl Hard Capsules for</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>